Idarucizumab for dabigatran reversal in daily clinical practice-Reference-Cited by-同舟云学术

Idarucizumab for dabigatran reversal in daily clinical practice

Published:2020-03-13 Issue:10 Volume:37 Page:874-878
ISSN:0265-0215
Container-title:European Journal of Anaesthesiology
language:en
Short-container-title:

Author:

Vene Nina,Mavri Alenka,Božič-Mijovski Mojca,Gregorič Minja,Uštar Katja K.,Žerjav Urša,Gradišek Primož,Stecher Adela,Frol Senta,Nedog Viljenka,Detkova Nataliya,Kosi Iwona E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference26 articles.

1. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

2. The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study;Connolly;Circulation,2013

3. Idarucizumab: the antidote for reversal of dabigatran;Eikelboom;Circulation,2015

4. Idarucizumab for dabigatran reversal – full cohort analysis;Pollack;N Engl J Med,2017

5. Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases;Vosko;J Thromb Thrombolysis,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke — a single centre experience;Neurologia i Neurochirurgia Polska;2023-12-29

2. Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes;Thrombosis Research;2023-08

3. Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases;Research and Practice in Thrombosis and Haemostasis;2023-07

4. Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials;Medicina;2023-05-04

5. Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke;Journal of Thrombosis and Thrombolysis;2023-02-04